Boston Heart Blog
Filtered By: Health & Wellness | 2018
MENUMENU
In Good Health
PCR and Antibodies Are Complementary Tests For Coronavirus Status
Join Michael Dansinger, MD, Vice President of Clinical Affairs, as he discusses the clinical rationale for determining patient coronavirus status by simultaneous combining PCR testing with blood antibody testing for IgM and IgG. Evidence suggests the combination of both modalities are complementary and superior than either modality alone. For more medical education resources please Read more
June 16, 2020
PCR and Antibodies Are Complementary Tests For Coronavirus Status
Join Michael Dansinger, MD, Vice President of Clinical Affairs, as he discusses the clinical rationale for determining patient coronavirus status...
Read more
COVID-19 Antibody Testing at Boston Heart Diagnostics
Join Ernst J. Schaefer, MD, Founder and Chief Medical Officer as he discusses the COVID-19 (SARS-CoV2) IgM and IgG antibody testing at Boston Heart Diagnostics. IgM antibodies eliminate pathogens in the early stages of infection. IgG antibodies develop later and provide the majority of antibody-based immunity against invading pathogens including COVID-19. These tests help identify Read more
April 06, 2020
COVID-19 Antibody Testing at Boston Heart Diagnostics
Join Ernst J. Schaefer, MD, Founder and Chief Medical Officer as he discusses the COVID-19 (SARS-CoV2) IgM and IgG antibody...
Read more
Eurofins’ U.S. Clinical Diagnostics Network Launches Coronavirus (COVID-19) Antibody Testing
Eurofins’ U.S. Clinical Diagnostics Network Launches Coronavirus (COVID-19) Antibody Testing New test may help determine past COVID infection Framingham, MA – April 3, 2020 – The Eurofins’ U.S. Clinical Diagnostics network announced today that blood-based antibody testing for Coronavirus SARS-CoV-2 will begin Monday, April 6 at Boston Heart Diagnostics, a Eurofins subsidiary. Given Read more
April 03, 2020
Eurofins’ U.S. Clinical Diagnostics Network Launches Coronavirus (COVID-19) Antibody Testing
Eurofins’ U.S. Clinical Diagnostics Network Launches Coronavirus (COVID-19) Antibody Testing New test may help determine past COVID infection ...
Read more
The Beta Cell Function And Risk Index
Join Michael Dansinger, MD, Vice President of Clinical Affairs, as he discusses the Boston Heart Beta Cell Function and Risk Index.TM Using calculations based on fasting glucose and insulin, this new clinical tool helps clinicians assess a patient’s degree of pancreatic beta cell activity, and suggests various evidence-based treatment considerations to optimize beta cell function Read more
March 10, 2020
The Beta Cell Function And Risk Index
Join Michael Dansinger, MD, Vice President of Clinical Affairs, as he discusses the Boston Heart Beta Cell Function and Risk...
Read more
Boston Heart Diagnostics Reaches Agreement with DOJ to Resolve Legacy Claims
Boston Heart Press Release 11-26-19 Boston Heart Diagnostics Reaches Agreement with DOJ to Resolve Legacy Claims Read more
November 26, 2019
Boston Heart Diagnostics Reaches Agreement with DOJ to Resolve Legacy Claims
Boston Heart Press Release 11-26-19 Boston Heart Diagnostics Reaches Agreement with DOJ to Resolve Legacy Claims
Read more